Komori
Earnings presentation9221FULUHASHI EPO CORPORATIONInformation and Communications, Services and Others

FY2026 Q2 Financial Results Presentation Materials

For Q2 FY2026, net sales and operating income exceeded the year-earlier period and both reached record highs. Ordinary income and interim net income attributable to owners of the parent were lower than in the year-earlier period, mainly due to the reversal of insurance surrender value refunds.

Worth reading
88Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
504
¥ millions (operating profit)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings presentation2026年3月期 第2四半期10 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales4,873 million yen+8.8%
Operating profit504 million yen+13.6%
Ordinary income498 million yen-24.8%
Net income¥368 million -17.2%interim net income attributable to owners of the parent
Gross Profit Margin43.7 %
Operating profit margin10.4 %
Results for the three months of the current quarter
Biomaterials Business
Net Sales1,838百万円
Operating profit¥353 million
Resource-Circulation Business
Net Sales¥456 million
Operating profit¥33 million
Full-year earnings forecast
Net Sales
10,322 million yen
Gross profit
4,757 million yen
Operating profit
1,303 million yen
Ordinary income
1,335 million yen
Net income
905 million yen net income attributable to owners of the parent
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales47.2%
Gross profit44.8%
Operating profit38.7%
Ordinary income37.3%
Net income40.7%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Biomaterials+¥307 million
  • Resource Circulation+¥106 million
  • Other-¥19 million
  • 売上原価・販管費等-123百万円、-62百万円、-61百万円、-54百万円、-33百万円
New initiatives
  • 名古屋CEセンターの稼働
  • Introduction of a Shareholder Benefit Program
  • 12ヶ所の工場新設案件の推進
  • 経営戦略本部、事業開発部門、サステナビリティ推進部門等の設置
Key KPIsA metric the company considers important as a management benchmark.
  • 木質バイオマス取扱量目標100 万t/年
  • Number of locations22 Locations
  • 進行中の工場新設案件12 Locations
Segment results
Biomaterials Business
Net Sales
3,559 million yen+9.1%
Segment profit
450 million yen-4.0%
Resource-Circulation Business
Net Sales
816 million yen+14.6%
Segment profit
35 million yen
Other businesses
Net Sales
686 million yen-4.4%
Segment profit
24 million yen
Medium-term management plan targets
Target fiscal yearFiscal year ending March 2028
Net Sales¥15 billion
Operating profit¥3 billion
Operating profit margin20%
ROEOver 15%
木質バイオマス取扱量年間100万t
Financial targets
ROE
TargetOver 15%
Actual results2025年3月期19.5%
Number of stores and locations
Number of locations at period end22
Number of store openings and closures during the period愛知第八工場（一宮）稼働、名古屋CEセンター稼働。新設案件12ヶ所進行中。出店・閉鎖数の明示はなし
Number of employees
Number of Employees483 Number連結、2025年9月末
Annual Dividend
Annual dividend per share30円（予想）
Interim Dividend¥15
Payout ratio
Rate将来的な連結配当性向35%程度を目標
Contents of this document
ItemDetails
Document typeEarnings presentation
Fiscal Period Covered2026年3月期 第2四半期
Net Sales4,873 million yen (YoY +8.8%)
Operating profit504 million yen (YoY +13.6%)
Ordinary income498 million yen (YoY -24.8%)
Net income¥368 million (interim net income attributable to owners of the parent) (YoY -17.2%)
Gross Profit Margin43.7 %
Operating profit margin10.4 %
Results for the three months of the current quarterBiomaterials Business Net Sales 1,838百万円 / Operating profit ¥353 million / Resource-Circulation Business Net Sales ¥456 million / Operating profit ¥33 million
Full-year earnings forecastNet Sales 10,322 million yen / Gross profit 4,757 million yen / Operating profit 1,303 million yen / Ordinary income 1,335 million yen / Net income 905 million yen (net income attributable to owners of the parent)
Progress against full-year forecastNet Sales 47.2% / Gross profit 44.8% / Operating profit 38.7% / Ordinary income 37.3% / Net income 40.7%
Segment resultsBiomaterials Business Net Sales 3,559 million yen (YoY +9.1%) / Segment profit 450 million yen (YoY -4.0%) / Resource-Circulation Business Net Sales 816 million yen (YoY +14.6%) / Segment profit 35 million yen / Other businesses Net Sales 686 million yen (YoY -4.4%) / Segment profit 24 million yen
Breakdown of Factors Affecting the ChangeFactors Biomaterials / Amount +¥307 million, Factors Resource Circulation / Amount +¥106 million, Factors Other / Amount -¥19 million, Factors 売上原価・販管費等 / Amount -123百万円、-62百万円、-61百万円、-54百万円、-33百万円
Key KPIsIndicator name 木質バイオマス取扱量目標 / Value 100 万t/年 / Year on year against the same period last year Not disclosed, Indicator name Number of locations / Value 22 Locations / Year on year against the same period last year Not disclosed, Indicator name 進行中の工場新設案件 / Value 12 Locations / Year on year against the same period last year Not disclosed
Number of stores and locationsNumber of locations at period end 22 / Number of store openings and closures during the period 愛知第八工場（一宮）稼働、名古屋CEセンター稼働。新設案件12ヶ所進行中。出店・閉鎖数の明示はなし
Number of employeesNumber of Employees 483 名（連結、2025年9月末） / Changes during the period and hiring plan Not disclosed
Medium-term management plan targetsTarget fiscal year Fiscal year ending March 2028 / Net Sales ¥15 billion / Operating profit ¥3 billion / Operating profit margin 20% / ROE Over 15% / 木質バイオマス取扱量 年間100万t
Financial targetsROE Target Over 15% / Actual results 2025年3月期19.5%
Annual DividendAnnual dividend per share 30円（予想） / Interim Dividend ¥15 / Year-end dividend Not disclosed
Payout ratioRate 将来的な連結配当性向35%程度を目標 / Total payout ratio Not disclosed / DOE Not disclosed
New initiatives名古屋CEセンターの稼働, Introduction of a Shareholder Benefit Program, 12ヶ所の工場新設案件の推進, 経営戦略本部、事業開発部門、サステナビリティ推進部門等の設置
Items this document does not state (10)
Selling, general and administrative expensesSelf-assessment against the planUnit price and quantity metricsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

量的拡大、単価改定、名古屋CEセンターおよび愛知第八工場（一宮）の稼働により売上が増加した。営業利益は増収効果があった一方、人件費、減価償却費、管理・輸送コストなどが増加した。経常利益と中間純利益の減少については、前年同期に保険解約返戻金194百万円を計上していた反動が主因として示されている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FY2026 Q2 Financial Results Presentation Materials | FULUHASHI EPO CORPORATION (9221) timely disclosure | Komori